Studio Investment Management LLC Acquires 165 Shares of UnitedHealth Group Incorporated $UNH

Studio Investment Management LLC raised its position in UnitedHealth Group Incorporated (NYSE:UNH) by 2.3% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 7,427 shares of the healthcare conglomerate’s stock after purchasing an additional 165 shares during the period. Studio Investment Management LLC’s holdings in UnitedHealth Group were worth $2,317,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of the company. Private Capital Advisors Inc. increased its stake in UnitedHealth Group by 1.6% in the second quarter. Private Capital Advisors Inc. now owns 37,685 shares of the healthcare conglomerate’s stock valued at $11,757,000 after purchasing an additional 608 shares in the last quarter. D.A. Davidson & CO. increased its stake in UnitedHealth Group by 33.7% in the second quarter. D.A. Davidson & CO. now owns 56,801 shares of the healthcare conglomerate’s stock valued at $17,720,000 after purchasing an additional 14,315 shares in the last quarter. Blume Capital Management Inc. increased its position in shares of UnitedHealth Group by 954.3% during the second quarter. Blume Capital Management Inc. now owns 3,068 shares of the healthcare conglomerate’s stock worth $957,000 after acquiring an additional 2,777 shares in the last quarter. Gables Capital Management Inc. increased its position in shares of UnitedHealth Group by 219.8% during the second quarter. Gables Capital Management Inc. now owns 4,065 shares of the healthcare conglomerate’s stock worth $1,268,000 after acquiring an additional 2,794 shares in the last quarter. Finally, Cullen Frost Bankers Inc. increased its position in shares of UnitedHealth Group by 4.8% during the second quarter. Cullen Frost Bankers Inc. now owns 108,986 shares of the healthcare conglomerate’s stock worth $34,000,000 after acquiring an additional 4,955 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

NYSE UNH opened at $365.47 on Wednesday. The firm has a 50-day moving average of $333.70 and a 200-day moving average of $341.28. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The stock has a market cap of $331.00 billion, a PE ratio of 15.83, a P/E/G ratio of 2.36 and a beta of 0.47. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The company had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business’s quarterly revenue was up 12.9% compared to the same quarter last year. During the same quarter in the prior year, the business posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were paid a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 38.30%.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on UNH shares. Zacks Research raised shares of UnitedHealth Group from a “strong sell” rating to a “hold” rating in a research report on Monday, October 6th. Bank of America increased their target price on shares of UnitedHealth Group from $350.00 to $390.00 and gave the stock a “neutral” rating in a report on Wednesday, October 8th. Robert W. Baird restated an “underperform” rating and set a $198.00 target price (down previously from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Oppenheimer reduced their target price on shares of UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating for the company in a report on Wednesday, July 30th. Finally, UBS Group reiterated a “buy” rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. Eighteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have assigned a Sell rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average price target of $385.13.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.